NetApp (NTAP) reported fiscal Q4 non-GAAP earnings and revenue late Thursday above market expectations, and its forecast for the full financial year also beat consensus.

Shares soared 27% amid a surge in intraday trading volume to over 6.5 million from a daily average of roughly 2.5 million.

Dell Technologies (DELL) reported overnight fiscal Q1 financial results that topped analyst estimates and issued higher-than-expected guidance for fiscal Q2 and the full year.

Shares surged 29% as intraday trading volume catapulted to over 27.1 million from a daily average of about 7.99 million.

Replimune (REPL) said Friday it will, in the coming days, resubmit a biologics license application with the US Food and Drug Administration for vusolimogene oderparepvec, its experimental treatment for advanced melanoma.

Shares catapulted 83% following an increase in intraday trading volume to over 39.8 million from a daily average of about 6.19 million.

Price: 180.63, Change: +38.23, Percent Change: +26.85